Stephen E. Mercer

2.4k total citations
51 papers, 1.8k citations indexed

About

Stephen E. Mercer is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Stephen E. Mercer has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Stephen E. Mercer's work include Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers) and Migraine and Headache Studies (4 papers). Stephen E. Mercer is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers) and Migraine and Headache Studies (4 papers). Stephen E. Mercer collaborates with scholars based in United States, Germany and United Kingdom. Stephen E. Mercer's co-authors include Eileen Friedman, Daina Z. Ewton, Xiaobing Deng, Robert Phelps, Valerie R. Yanofsky, Kideok Jin, Zhongfa Yan, Mark L. Burleson, Yonglong Zou and Richard E. Olson and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Stephen E. Mercer

50 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen E. Mercer United States 22 886 428 225 159 157 51 1.8k
Hiroko Masuda Japan 26 1.1k 1.2× 1.3k 3.0× 122 0.5× 99 0.6× 248 1.6× 73 2.9k
Claudia Linker United States 25 1.5k 1.7× 285 0.7× 233 1.0× 80 0.5× 311 2.0× 48 3.0k
Elena Rivera Argentina 26 979 1.1× 235 0.5× 98 0.4× 53 0.3× 214 1.4× 61 1.8k
Carolyn A. Foster Austria 20 2.0k 2.2× 237 0.6× 203 0.9× 94 0.6× 74 0.5× 34 3.0k
Hargita Hegyesi Hungary 21 812 0.9× 341 0.8× 75 0.3× 56 0.4× 63 0.4× 59 1.5k
R Joseph United States 23 691 0.8× 184 0.4× 42 0.2× 99 0.6× 66 0.4× 65 1.6k
Jacques Pouysségur France 18 1.7k 1.9× 276 0.6× 95 0.4× 172 1.1× 109 0.7× 21 2.3k
Yingting Zhu China 30 648 0.7× 194 0.5× 41 0.2× 167 1.1× 193 1.2× 84 2.1k
Miho Takahashi Japan 25 914 1.0× 133 0.3× 147 0.7× 87 0.5× 151 1.0× 64 1.7k
Gunnar Houge Norway 33 1.8k 2.1× 187 0.4× 221 1.0× 390 2.5× 812 5.2× 112 3.3k

Countries citing papers authored by Stephen E. Mercer

Since Specialization
Citations

This map shows the geographic impact of Stephen E. Mercer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen E. Mercer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen E. Mercer more than expected).

Fields of papers citing papers by Stephen E. Mercer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen E. Mercer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen E. Mercer. The network helps show where Stephen E. Mercer may publish in the future.

Co-authorship network of co-authors of Stephen E. Mercer

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen E. Mercer. A scholar is included among the top collaborators of Stephen E. Mercer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen E. Mercer. Stephen E. Mercer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Yanling, Hong Cai, Julia Smith, et al.. (2024). Evaluation of antisense oligonucleotide therapy targeting Hsd17b13 in a fibrosis mice model. Journal of Lipid Research. 65(3). 100514–100514. 9 indexed citations
2.
Hagedorn, Peter, Jeffrey M. Brown, Amy Easton, et al.. (2022). Acute Neurotoxicity of Antisense Oligonucleotides After Intracerebroventricular Injection Into Mouse Brain Can Be Predicted from Sequence Features. Nucleic Acid Therapeutics. 32(3). 151–162. 36 indexed citations
3.
Knouse, Kyle W., Wei Hao, Natalia M. Padial, et al.. (2021). A P(V) platform for oligonucleotide synthesis. Science. 373(6560). 1265–1270. 60 indexed citations
4.
Knouse, Kyle W., Justine N. deGruyter, Michael A. Schmidt, et al.. (2018). Unlocking P(V): Reagents for chiral phosphorothioate synthesis. Science. 361(6408). 1234–1238. 201 indexed citations
5.
Luo, Guanglin, Ling Chen, Charles M. Conway, et al.. (2012). Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine. ACS Medicinal Chemistry Letters. 3(4). 337–341. 32 indexed citations
6.
Furmanczyk, Paul S., et al.. (2012). Langerhans cell sarcoma in a patient with hairy cell leukemia: common clonal origin indicated by identical immunoglobulin gene rearrangements. Journal of Cutaneous Pathology. 39(6). 644–650. 19 indexed citations
7.
Mercer, Stephen E., et al.. (2012). Evaluation of the prognostic significance of follicular extension in actinic keratoses.. PubMed. 5(4). 25–8. 9 indexed citations
8.
Mercer, Stephen E., et al.. (2011). Identification of SLC26A4 Mutations in Patients with Hearing Loss and Enlarged Vestibular Aqueduct Using High-Resolution Melting Curve Analysis. Genetic Testing and Molecular Biomarkers. 15(5). 365–368. 10 indexed citations
9.
10.
Mercer, Stephen E., et al.. (2010). Pagetoid Reticulosis After Radiotherapy of Primary Cutaneous Anaplastic Large-Cell Lymphoma. American Journal of Dermatopathology. 32(1). 79–82. 6 indexed citations
11.
Garner, C. Edwin, Eric Solon, Chii‐Ming Lai, et al.. (2008). Role of P-Glycoprotein and the Intestine in the Excretion of DPC 333 [(2R)-2-{(3R)-3-Amino-3-[4-(2-methylquinolin-4-ylmethoxy)phenyl]-2-oxopyrrolidin-1-yl}-N-hydroxy-4-methylpentanamide] in Rodents. Drug Metabolism and Disposition. 36(6). 1102–1110. 6 indexed citations
12.
Prasad, C. V. C., Stephen E. Mercer, Gene M. Dubowchik, & John E. Macor. (2007). Enantioselective synthesis of aminobenzazepinones. Tetrahedron Letters. 48(15). 2661–2665. 9 indexed citations
13.
Mercer, Stephen E. & Eileen Friedman. (2006). Mirk/Dyrk1B: A Multifunctional Dual-Specificity Kinase Involved in Growth Arrest, Differentiation, and Cell Survival. Cell Biochemistry and Biophysics. 45(3). 303–315. 52 indexed citations
14.
Mercer, Stephen E., et al.. (2006). Mirk/Dyrk1b Mediates Cell Survival in Rhabdomyosarcomas. Cancer Research. 66(10). 5143–5150. 45 indexed citations
15.
Gilmore, John L., Bryan W. King, Thomas Maduskuie, et al.. (2006). Synthesis and structure–activity relationship of a novel, achiral series of TNF-α converting enzyme inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(10). 2699–2704. 38 indexed citations
16.
Jin, Kideok, Seunghwan Lim, Stephen E. Mercer, & Eileen Friedman. (2005). The Survival Kinase Mirk/dyrk1B Is Activated through Rac1-MKK3 Signaling. Journal of Biological Chemistry. 280(51). 42097–42105. 14 indexed citations
17.
Deng, Xiaobing, Daina Z. Ewton, Stephen E. Mercer, & Eileen Friedman. (2004). Mirk/dyrk1B Decreases the Nuclear Accumulation of Class II Histone Deacetylases during Skeletal Muscle Differentiation. Journal of Biological Chemistry. 280(6). 4894–4905. 61 indexed citations
18.
Deng, Xiaobing, et al.. (2004). The Cyclin-dependent Kinase Inhibitor p27Kip1 Is Stabilized in G0 by Mirk/dyrk1B Kinase. Journal of Biological Chemistry. 279(21). 22498–22504. 116 indexed citations
19.
Mercer, Stephen E., et al.. (2001). An incremental brake force protocol for arm crank anaerobic testing of wheelchair athletes. Sports medicine, training, and rehabilitation. 10(2). 123–136.
20.
Mercer, Stephen E.. (1979). Agenesis or atrophy of the testis and vas deferens.. PubMed. 22(3). 245–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroko Masuda Breakdown of academic impact, for papers by Claudia Linker Breakdown of academic impact, for papers by Elena Rivera Breakdown of academic impact, for papers by Carolyn A. Foster Breakdown of academic impact, for papers by Hargita Hegyesi Breakdown of academic impact, for papers by R Joseph Breakdown of academic impact, for papers by Jacques Pouysségur Breakdown of academic impact, for papers by Yingting Zhu Breakdown of academic impact, for papers by Miho Takahashi Breakdown of academic impact, for papers by Gunnar Houge
Rankless by CCL
2026